Glenmede Investment Management’s Viridian Therapeutics VRDN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$165K Buy
+11,835
New +$165K ﹤0.01% 1257